Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image
- PMLiVE

Pharmaceutical Market Europe – October 2022

ESMO 2022: changing the future of oncology; the complexities of current generation CAR-T therapies; why community engagement is vital

- PMLiVE

Pharmaceutical Market Europe – September 2022

The importance of support programmes to improve patient health; the fight against antimicrobial resistance; future-proofing pharma supply chains

- PMLiVE

Pharmaceutical Market Europe – July/ August 2022

A creative awakening – bringing innovation to patients; Parkinson’s disease and the microbiome; Rare diseases – changing the standard of care

- PMLiVE

Pharmaceutical Market Europe – June 2022

A creative awakening – bringing innovation to patients; Parkinson’s disease and the microbiome; Rare diseases – changing the standard of care

- PMLiVE

Pharmaceutical Market Europe – May 2022

How patients and HCPs are powering a new era of launch excellence; Tackling life sciences disputes; Clinical trials and the patient perspective

- PMLiVE

Pharmaceutical Market Europe – April 2022

How patients and HCPs are powering a new era of launch excellence; Tackling life sciences disputes; Clinical trials and the patient perspective

- PMLiVE

Pharmaceutical Market Europe – March 2022

Unleashing the power of medical affairs, Takeda looks at the challenges facing combination treatments, MHRA: COVID-19 vaccines, treatments and tests

- PMLiVE

Pharmaceutical Market Europe – February 2022

Charting patient pathways with precision for better healthcare, Fairer and faster access to medicines in the NHS, Greater price transparency

- PMLiVE

Pharmaceutical Market Europe – January 2022

Pharma congresses and conferences – virtual, hybrid or in-person? CVD: Europe’s hidden crisis; Research into autoimmune and inflammatory diseases

- PMLiVE

Pharmaceutical Market Europe – December 2021

Patient-centricity – the importance of face-to-face support; why AMR requires new, innovative and durable tools to treat microbial infections

- PMLiVE

Pharmaceutical Market Europe – November 2021

Achieving connected teamwork for patients and HCPs, the impact of corporate social responsibility, using digital technology for chronic conditions

- PMLiVE

Pharmaceutical Market Europe – October 2021

Time for pharma to ditch its cautious approach to creativity in comms, Alzheimer’s disease and beyond, Amarin is rethinking cardiovascular risk